Skip to main content

Table 2 Adverse events

From: Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-

  

Grade

  

1

2

3

4

3/4

Hematological

      

Leukocytopenia

Level 1 (n = 3)

1

0

0

0

0

 

2 (n = 3)

1

0

1

0

1

 

3 (n = 3)

1

0

0

0

0

Neutropenia

1

0

0

0

0

0

 

2

0

0

1

0

1

 

3

1

0

0

0

0

Anemia

1

0

0

0

0

0

 

2

0

0

1

0

1

 

3

0

0

0

0

0

Thrombocytopenia

1

1

0

1

0

1

 

2

2

0

0

0

0

 

3

0

2

0

0

0

Nonhematological

      

Nausea

1

0

1

0

0

0

 

2

0

0

0

0

0

 

3

1

0

1*

0

1

Diarrhea

1

0

0

0

0

0

 

2

0

0

0

0

0

 

3

0

0

1*

0

1

AST/ALT elevation

1

1

0

0

0

0

 

2

2

0

0

0

0

 

3

1

0

0

0

0

Bilirubin elevation

1

1

1

0

0

0

 

2

0

1

0

0

0

 

3

1

0

0

0

0

Creatinin elevation

1

1

0

0

0

0

 

2

0

0

0

0

0

 

3

1

0

0

0

0

  1. *: Dose-limiting toxicity, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase.